Best Diagnostic & Research Stocks to Buy Now (2025)Top diagnostic & research stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best diagnostic & research stocks to buy now. Learn More.
Industry: Diagnostics & Research
B
Diagnostics & Research is Zen Rated B and is the 54th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SHC | SOTERA HEALTH CO | $4.49B | 5.80% | 0.80% | 8.77% | 7.10% | 6.48 | 2.46 | 55.20% | 2.20% | 22.75% | ||
| IDXX | IDEXX LABORATORIES INC | $57.51B | 67.80% | 31.10% | 61.40% | 52.70% | 1.17 | 1.18 | 61.70% | 24.70% | 31.45% | ||
| A | AGILENT TECHNOLOGIES INC | $41.61B | 20.00% | 10.10% | 14.62% | 21.30% | 0.92 | 2.25 | 52.60% | 18.00% | 22.26% | ||
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL INC | $8.25B | -2.50% | -1.10% | 1.36% | 1.60% | 1.19 | 1.37 | 32.30% | -2.10% | 2.15% | ||
| LH | LABCORP HOLDINGS INC | $20.78B | 10.20% | 4.70% | 8.52% | 11.80% | 1.10 | 1.55 | 28.40% | 6.20% | 9.68% | ||
| ILMN | ILLUMINA INC | $18.71B | 30.00% | 11.40% | 23.61% | 21.30% | 1.59 | 1.43 | 66.20% | 16.40% | 23.20% | ||
| QGEN | QIAGEN NV | $9.59B | 10.70% | 6.40% | 11.21% | 17.50% | 0.66 | 1.61 | 63.00% | 18.30% | 25.79% | ||
| PRPO | PRECIPIO INC | $33.44M | -15.00% | -10.20% | -11.72% | -76.20% | 0.53 | 0.93 | 44.70% | -8.50% | -7.98% | ||
| MEDP | MEDPACE HOLDINGS INC | $16.87B | 91.90% | 23.70% | 109.05% | -179.60% | 4.97 | 0.57 | 31.10% | 18.40% | 21.69% | ||
| BNR | BURNING ROCK BIOTECH LTD | $131.37M | -23.70% | -15.80% | -22.57% | -66.90% | 0.46 | 3.22 | 72.10% | -26.10% | -25.03% | ||
| TMO | THERMO FISHER SCIENTIFIC INC | $213.27B | 13.10% | 6.60% | 9.63% | 15.60% | 1.02 | 1.50 | 41.30% | 15.00% | 19.40% | ||
| IQV | IQVIA HOLDINGS INC | $35.72B | 21.40% | 4.60% | 11.35% | 17.00% | 3.64 | 0.70 | 33.80% | 8.10% | 14.43% | ||
| DGX | QUEST DIAGNOSTICS INC | $19.83B | 13.70% | 6.00% | 10.92% | 15.80% | 1.23 | 1.13 | 33.30% | 8.90% | 14.15% | ||
| DHR | DANAHER CORP | $149.89B | 6.90% | 4.40% | 6.04% | 16.50% | 0.56 | 1.52 | 59.50% | 14.40% | 18.32% | ||
| CDNA | CAREDX INC | $879.84M | 15.20% | 10.90% | 11.62% | 16.90% | 0.36 | 3.30 | 66.90% | 15.20% | 11.97% | ||
| EXAS | EXACT SCIENCES CORP | $13.19B | -40.40% | -16.90% | -17.98% | -24.60% | 1.36 | 2.72 | 67.40% | -32.00% | -31.01% | ||
| NEOG | NEOGEN CORP | $1.35B | -43.80% | -28.00% | -31.07% | -66.30% | 0.59 | 3.58 | 46.40% | -117.60% | -113.23% | ||
| FLGT | FULGENT GENETICS INC | $697.27M | -4.50% | -4.20% | -5.21% | -6.40% | 0.08 | 6.01 | 40.00% | -16.80% | -19.39% | ||
| RDNT | RADNET INC | $6.01B | -1.60% | -0.40% | 2.02% | 2.00% | 2.51 | 2.00 | 11.60% | -0.80% | 3.14% | ||
| WAT | WATERS CORP | $22.15B | 31.30% | 13.90% | 23.31% | 28.30% | 1.09 | 1.53 | 59.00% | 20.90% | 27.11% | ||
| TWST | TWIST BIOSCIENCE CORP | $1.90B | -18.40% | -13.80% | -15.21% | -26.50% | 0.35 | 3.90 | 49.20% | -23.50% | -23.36% | ||
| XGN | EXAGEN INC | $234.11M | -138.20% | -36.90% | -30.92% | -39.40% | 2.46 | 4.08 | 59.90% | -29.90% | -24.27% | ||
| NEO | NEOGENOMICS INC | $1.35B | -13.00% | -7.60% | -8.55% | -15.20% | 0.64 | 3.91 | 43.50% | -16.00% | -15.40% | ||
| MTD | METTLER TOLEDO INTERNATIONAL INC | $29.66B | -459.70% | 25.20% | 47.70% | 33.80% | -14.14 | 1.12 | 59.90% | 21.50% | 28.29% | ||
| MYGN | MYRIAD GENETICS INC | $613.35M | -73.90% | -46.60% | -72.14% | -111.80% | 0.95 | 2.33 | 70.40% | -48.50% | -50.71% | ||
| GH | GUARDANT HEALTH INC | $11.98B | N/A | -29.30% | -37.91% | -23.20% | -4.60 | 3.50 | 63.80% | -44.20% | -43.68% | ||
| ICLR | ICON PLC | $12.50B | 6.30% | 3.60% | 6.18% | 18.50% | 0.77 | 1.06 | 28.10% | 7.40% | 10.13% | ||
| CSTL | CASTLE BIOSCIENCES INC | $979.86M | -2.70% | -2.30% | -3.70% | -5.70% | 0.21 | 6.47 | 79.90% | -3.60% | -5.46% | ||
| CAI | CARIS LIFE SCIENCES INC | $8.21B | N/A | N/A | N/A | N/A | 1.11 | 9.24 | N/A | N/A | N/A | ||
| RVTY | REVVITY INC | $10.50B | 3.10% | 1.90% | 3.38% | 7.80% | 0.65 | 1.75 | 55.30% | 8.40% | 13.10% | ||
| GRAL | GRAIL INC | $3.05B | -18.00% | -15.20% | -22.75% | -104.70% | 0.17 | 9.23 | -56.50% | -329.90% | -445.82% | ||
| PRE | PRENETICS GLOBAL LTD | $168.51M | -30.10% | -23.40% | -32.33% | -54.30% | 0.32 | 2.02 | 41.60% | -98.60% | -113.43% | ||
| BDSX | BIODESIX INC | $68.42M | -504.40% | -43.90% | -45.53% | -31.60% | -52.52 | 1.84 | 79.80% | -49.30% | -40.07% | ||
| MDXH | MDXHEALTH SA | $23.36M | -375.00% | -22.00% | -15.40% | -12.40% | -160.27 | 1.31 | 63.50% | -35.00% | -15.47% | ||
| OPK | OPKO HEALTH INC | $1.03B | -13.70% | -8.70% | -2.63% | -5.60% | 0.53 | 3.70 | 35.30% | -28.10% | -7.49% | ||
| NTRA | NATERA INC | $27.30B | -18.30% | -11.70% | -13.23% | -25.70% | 0.40 | 3.87 | 61.80% | -10.40% | -9.87% | ||
| ACRS | ACLARIS THERAPEUTICS INC | $244.72M | -92.40% | -68.40% | -73.74% | -94.90% | 0.38 | 5.06 | 14.90% | -732.40% | -732.42% | ||
| PSNL | PERSONALIS INC | $679.27M | -47.60% | -35.10% | -40.19% | -48.10% | 0.36 | 6.10 | 31.40% | -113.70% | -113.58% | ||
| NOTV | INOTIV INC | $40.54M | -51.40% | -11.30% | -7.85% | -8.20% | 3.86 | 1.51 | 21.90% | -18.20% | -10.63% | ||
| STIM | NEURONETICS INC | $187.65M | -151.30% | -31.60% | -31.45% | -27.20% | 4.17 | 2.24 | 50.40% | -34.30% | -28.22% | ||
| DRIO | DARIOHEALTH CORP | $30.92M | -88.70% | -52.60% | -44.65% | -153.60% | 0.69 | 3.30 | 55.00% | -219.20% | -162.13% | ||
| ISPC | ISPECIMEN INC | $3.73M | -395.20% | -121.70% | -1,161.87% | 323.10% | 8.70 | 0.23 | 32.60% | -172.50% | -169.69% | ||
| LAB | STANDARD BIOTOOLS INC | $435.47M | -26.20% | -19.80% | -25.61% | -40.00% | 0.31 | 5.16 | 49.00% | -78.10% | -76.21% | ||
| BIAF | BIOAFFINITY TECHNOLOGIES INC | $2.06M | -930.20% | -200.10% | -535.24% | -892.70% | -3.22 | 0.65 | 29.90% | -152.20% | -150.71% | ||
| BNBX | APPLIED DNA SCIENCES INC | $4.47M | -681.60% | -522.00% | -166.93% | -1,287.60% | 0.41 | 2.77 | 39.60% | -2,047.40% | -399.87% | ||
| FONR | FONAR CORP | $97.14M | 4.60% | 3.70% | 5.74% | 6.50% | 0.33 | 8.45 | 41.10% | 7.50% | 10.99% | ||
| SERA | SERA PROGNOSTICS INC | $117.61M | -45.90% | -34.30% | -37.08% | -49.10% | 0.27 | 1.73 | -16.70% | -30,306.50% | -30,290.74% | ||
| NDRA | ENDRA LIFE SCIENCES INC | $3.92M | -283.00% | -186.40% | -392.88% | -398.60% | 0.91 | 3.21 | N/A | N/A | N/A | ||
| TRIB | TRINITY BIOTECH PLC | $17.78M | N/A | -33.00% | -30.53% | -19.20% | -3.94 | 1.28 | 34.80% | -51.60% | -35.31% | ||
| IMDX | INSIGHT MOLECULAR DIAGNOSTICS INC | $190.61M | -2,898.10% | -117.30% | -144.31% | -1,076.10% | 45.01 | 4.04 | 54.50% | -1,489.70% | -1,487.01% | ||
| MYNZ | MAINZ BIOMED NV | $5.81M | N/A | -207.80% | -508.89% | -2,883.90% | 2.89 | 0.52 | 67.50% | -2,874.70% | -2,942.01% | ||
| VNRX | VOLITIONRX LTD | $46.37M | N/A | -237.40% | 4,275.56% | 8,595.30% | -1.31 | 0.35 | 100.00% | -1,767.90% | -1,737.41% | ||
| XWEL | XWELL INC | $5.12M | N/A | -77.70% | -148.43% | -94.40% | -3.54 | 1.25 | 20.50% | -67.60% | -62.91% | ||
| CHEK | CHECK-CAP LTD | $7.90M | -226.20% | -198.10% | 1,809.55% | -390.80% | -1.26 | 0.15 | N/A | N/A | N/A | ||
| ADVB | ADVANCED BIOMED INC | $9.59M | -139.90% | -54.80% | -89.95% | 398.80% | 0.87 | 2.09 | N/A | N/A | N/A | ||
| PRPH | PROPHASE LABS INC | $12.38M | -230.20% | -67.10% | -154.17% | -66.60% | 2.68 | 0.96 | 60.40% | -1,241.10% | -757.69% |
Diagnostic & Research Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.